Wells Fargo’s Nanobiotix NBTX Stock Holding History

Wells Fargo’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.54K	Hold	200	–	–	﹤0.01%	6139
2026 Q1	$6.17K	Hold	200	–	–	﹤0.01%	6071
2025 Q4	$4.62K	Buy	+200	New	+$4.37K	﹤0.01%	6116

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's NBTX Position: Q2 2026 in Review

Wells Fargo held its Nanobiotix (NBTX) position steady in Q2 2026 at 200 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #6139.

Wells Fargo first reported a position in NBTX in Q4 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

Wells Fargo held 200 shares of Nanobiotix worth $7.54K as of Q2 2026.
Wells Fargo left its Nanobiotix share count unchanged in Q2 2026.
Nanobiotix made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6139 holding.
Wells Fargo first reported a position in Nanobiotix in Q4 2025 and has held it in 3 quarters since.
19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.